The DOI matches its Crossref record; 192 of the 198 references it cites were found in a registry or an index.
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Open accessAbstract
homeostasis, autophagy, the release of nitric oxide and inflammatory mediators and altered gene and protein expression that involved apoptosis. Dox also causes downregulation of DNA methyltransferase 1 (DNMT1) enzyme activity which leads to a reduction in the DNA methylation process. This hypomethylation causes dysregulation in the mitochondrial genes like peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1-alpha (PGC-1α), nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (TFAM) unit in the heart. Apart from DNA methylation, Dox treatment also alters the micro RNAs levels and histone deacetylase (HDAC) activity. Therefore, in the current review, we have provided a detailed update on the current understanding of the pathological mechanisms behind the well-known Dox-induced cardiotoxicity. Further, we have provided some of the most plausible pharmacological strategies which have been tested against Dox-induced cardiotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cumulative anthracycline dose is a major risk factor for severe cardiomyopathy development but young age at treatment, female sex, peak drug exposure and additional stress to the heart have also been implicated 161,162,163 .”
From Osteosarcoma (2022) · cites this paper as [163]
Citations
Cites
2 retracted
Suliman, H. B., Carraway, M. S., Ali, A. S., Reynolds, C. M., Welty‐Wolf, K. E., & Piantadosi, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32967 · Cited by 261
RetractedChoi, H. C., Song, P., Xie, Z., Wu, Y., Xu, J., Zhang, M., Dong, Y., Wang, S., Lau, K., & Zou, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803020200 · Cited by 85
RetractedAn integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
The ENCODE (ENCyclopedia Of DNA Elements) Project
(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G. C., Antosiewicz‐Bourget, J., O’Malley, R. C., Castanon, R., Klugman, S. A., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,595
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S. P., Crijns, H. J. G. M., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,425
Nitric Oxide Synthases: Properties and Catalytic Mechanism
Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 881
Research works printed but not linked: 6
- Gianni, 2008, Anthracycline cardiotoxicity: from bench to bedside, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 26, 3777, 10.1200/JCO.2007.14.9401 · DOI
- Chustecka, 2006, Cardiotoxicity of imatinib is a" surprise, Nat. Med., 24
- Martínez-Mateo, 2017, Report of cisplatin-induced cardiotoxicity: a side effect to monitor closely, J. Heart Health, 3
- Speth, 1988, Clinical pharmacokinetics of doxorubicin, Clin. Pharmacokinet., 15, 15, 10.2165/00003088-198815010-00002 · DOI
- Youngson, 2006, Collins dictionary of human biology, Collins
- Zhu, 2009, Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mTOR pathway, Circulation, 119, 99, 10.1161/CIRCULATIONAHA.108.799700 · DOI
Cited by
Sorted by citations
Items 401–500 of 915
Li, W., Cheng, X., Zhu, G., Hu, Y. C., Wang, Y., Niu, Y., Li, H., Aierken, A., Li, J., Ling, F., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1340855 · Cited by 7
Ioniţă, S., Popescu, R., Irimescu, I. N., Deaconu, M., Tarbă, N., Matei, C., Mihăilescu, M., Savu, D., & Berger, D. (2024) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2024.113176 · Cited by 7
c-Myc-XRCC2-FOS axis promotes the proliferation and the resistance to Doxorubicin of NSCLC
Zhang, P., Li, H., Gong, H., Tian, Y., Chen, F., Li, X., Xie, C., Tu, C., Qian, S., Tan, Y., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117315 · Cited by 7
Dev, W., Sultana, F., Li, H., Hu, D., Peng, Z., He, S., Zhang, H., Waqas, M., Geng, X., & Du, X. (2025) · Plant Science · doi:10.1016/j.plantsci.2025.112390 · Cited by 6
Mitochondrial ROS inhibition prevents doxorubicin-induced breast cancer cell migration and invasion
Capelôa, T., de Velde, J. A. V., Pranzini, E., Ippolito, L., Zampieri, L. X., Tardy, M., Vazeille, T., Provito, A., Carrà, G., Scalera, A., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113031 · Cited by 6
Kamal, N. H., Heikal, L., Bakr, B. A., Helmy, M. W., & Abdallah, O. Y. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114816 · Cited by 6
NEDD4L-Mediated Ubiquitination of GPX4 Exacerbates Doxorubicin-Induced Cardiotoxicity
Ke, J., Li, L., Chen, S., Liao, C., Peng, F., Chai, D., & Lin, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178201 · Cited by 6
Anticancer compounds from Streptomyces: insights from metagenomics and mechanistic perspective
Al-shaibani, M. M., Zin, N. M., Remali, J., Sidik, N. M., Al‐Mekhlafi, N. A., Mariappan, V., & Sukri, A. (2025) · Folia Microbiologica · doi:10.1007/s12223-025-01332-x · Cited by 6
fraeyenhove, J. V., Guerra, G., Hirsch, E., & Ghigo, A. (2025) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2025.102581 · Cited by 6
Shi, C., Liu, B., Lu, F., Wei, B., Yu, S., & Chen, P. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115293 · Cited by 6
Banik, B. K., Kundu, S., Achary, S. T., Das, B., Verma, S., Mugale, M. N., & Sahu, B. D. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.11.055 · Cited by 6
Li, Y., Ding, N., Liu, X., Si, Q., Wang, Y., Li, C., & Liu, Y.-L. (2026) · Biology · doi:10.3390/biology15030230 · Cited by 6
Multifunctional chitosan–doxorubicin nanocarriers: advancing targeted breast cancer chemotherapy
Mishra, G., Leharwani, M., Alqahtani, T., Shmrany, H. A., Gupta, G., Sahebkar, A., Patil, U. K., & Kesharwani, P. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02639-0 · Cited by 6
Qin, B., He, Z., Xie, L., Feng, S., Ye, J., Gui, J., Sun, X., & Sang, M. (2024) · Cancer Medicine · doi:10.1002/cam4.6951 · Cited by 6
Azizian, S., Khezri, S., Shabani, M., Atashbar, S., & Salimi, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-02998-9 · Cited by 6
Tiwari, V., Gupta, P., Malladi, N., Salgar, S., & Banerjee, S. K. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.04.212 · Cited by 6
Xu, H., Chen, F.-X., Li, K., Zhang, Q., Han, N., Li, T., Xu, Y., Chen, Y., & Chen, X. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01595-w · Cited by 6
Sobhy, M. H., Ismail, A., Abdel‐Hamid, M. S., Wagih, M., & Kamel, M. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03073-z · Cited by 6
Cabral, R. P., Ribeiro, A. P. D., Monte, M. G., Fujimori, A. S. S., Tonon, C. R., Ferreira, N. F., Bazan, S. G. Z., Minicucci, M. F., Zornoff, L. A. M., de Paiva, S. A. R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36834 · Cited by 6
Gawryś, O., Jíchová, Š., Miklovič, M., Husková, Z., Kikerlová, S., Sadowski, J., Kollárová-Brázdová, P., Lenčová-Popelová, O., Hošková, L., Imig, J. D., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-01865-7 · Cited by 6
Monte, M. G., Tonon, C. R., Fujimori, A. S. S., Ribeiro, A. P. D., Bazan, S. G. Z., Okoshi, K., Corrêa, C. R., Moretto, M. R., de Paiva, S. A. R., Zornoff, L. A. M., et al. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4492 · Cited by 6
Zhou, Y.-F., Fu, Y., Lai, Z.-Q., Xu, H., Shen, N., Long, J., Zhang, H., & Dong, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-75277-5 · Cited by 6
Reguli, A., Piskáčková, H. B., Lenčová-Popelová, O., Kollárová-Brázdová, P., Štěrba, M., Pedersen‐Bjergaard, S., & Štěrbová‐Kovaříková, P. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.343459 · Cited by 6
Yoshikawa, N., Hirata, N., Kurone, Y., & Shimoeda, S. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70066 · Cited by 6
Wu, C., Zhang, X. W., Wang, M., Sun, J., Chen, J., Guan, Y., & Pang, X. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03143-1 · Cited by 6
Shackebaei, D., Yari, K., Kakavandi, N. R., Gorgani, S., & Yarmohammadi, F. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01723-4 · Cited by 6
The cGAS/STING Pathway: Friend or Foe in Regulating Cardiomyopathy
Wang, W., Gao, Y., Lee, H. K., Yu, A. C., Kipp, M., Kaddatz, H., & Zhan, J. (2025) · Cells · doi:10.3390/cells14110778 · Cited by 7
Gadecka, A., Koblowska, M., Kossowska, H., Iwanicka‐Nowicka, R., Janiszewska, D., Mosieniak, G., Bojakowski, K., Goryca, K., & Bielak-Żmijewska, A. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02315-8 · Cited by 6
(2022) · Biointerface Research in Applied Chemistry · doi:10.33263/briac132.142 · Cited by 6
Noorian, M., Chamani, E., Salmani, F., Rezaei, Z., & Khorsandi, K. (2022) · Natural Product Research · doi:10.1080/14786419.2022.2069765 · Cited by 6
Khosroshahi, A. J., Mokhtari, B., & Badalzadeh, R. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07390-5 · Cited by 8
Ojo, A. S., Shittu, A., Amadife, S., Jackson, D., Grantham, M., Ali, A. S., & Sarma, R. (2023) · World Journal of Oncology · doi:10.14740/wjon1603 · Cited by 6
Chemotherapy periodization to maximize resistance training adaptations in oncology
Nunes, J. H. C., Cella, P. S., Guimarães, T. A. S., Buçu, I. P., & Deminice, R. (2023) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-023-04576-x · Cited by 6
Ibrahim, M. A., Khalifa, A. M., El‐Fadeal, N. M. A., Abdel-Karim, R. I., Elsharawy, A. F., Ellawindy, A., Galal, H. M., Nadwa, E. H., Shafee, M. A., & Galhom, R. A. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102239 · Cited by 6
Monica, A. B., Subadra, S. U. I., Amrillah, T., Taufiq, A., Sunaryono, S., Wisodo, H., Mufti, N., Darminto, D., & Aziz, M. S. A. (2023) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-023-08489-y · Cited by 6
SiRNF8 Delivered by DNA Framework Nucleic Acid Effectively Sensitizes Chemotherapy in Colon Cancer
Guo, Z., Song, H., Tian, Y., Xu, J., Zhang, G., Guo, Y., Shen, R., & Wang, D. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s437859 · Cited by 6
Ma, Y., Qiying, L., Hu, A., Jiang, S., Wang, S., Liu, R., Han, K., & Wang, J. (2022) · Bioengineering · doi:10.3390/bioengineering9090433 · Cited by 6
Shniakat, W. N., Al-Khateeb, E. H., Numan, N. A. M., Abbas, M. M., & Shakya, A. K. (2023) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol31isssuppl.pp92-99 · Cited by 6
Nie, Y., Wei, Y., Zhang, Y., Liang, Z., Lei, Z., Chang, M., & Peng, Y. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125154 · Cited by 5
Koo, K., Seo, S. J., Kim, C., Yang, H., Jin, Y., & Kim, T. H. (2025) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-025-01331-z · Cited by 5
Chang, C.-M., Wang, W., Mhone, T. G., Ho, W.-K., Chen, C., Ng, S. S.-C., Li, C., Kuo, C., Huang, C., & Kuo, W. (2025) · Journal of Cancer · doi:10.7150/jca.113578 · Cited by 5
Torshizi, S. R. N., Seyf, J. Y., Najafi, R., Ventura, D., Mahdavinezhad, A., Afshar, S., Jalilian, F. A., Shojaeian, A., Amini, R., & Pecic, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147169 · Cited by 5
Cheng, F., Zhao, M., Wang, Q., Xiong, H., Yu, K., Chen, C., Zhu, Y., Chen, Y., & Li, J. (2025) · Redox Report · doi:10.1080/13510002.2025.2565033 · Cited by 5
Ma, Y., Huo, X., Wong, C., Fengjie, Z., Li, S.-Z., Zhang, H., & Wei, L. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157492 · Cited by 5
Shim, N., Kim, J., Song, S., Yoo, H., Kim, Y., Oh, Y., Hwang, N., Goo, J., Hong, S., Yu, J., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202504414 · Cited by 5
Fertility under fire: how chemotherapy harms the ovaries and the science fighting back?
Zhou, J., Zhang, D., Yu, Y., & Zhou, Q. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-025-01950-6 · Cited by 5
Chen, W., Li, X., Pan, C., Chen, M., Ma, C., Li, Y., Han, L., Chen, P., Huang, Y., Lian, B., et al. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.02.020 · Cited by 5
Mandal, S., Gamit, N., Biswas, S., Rao, C. M., Sethi, G., & Warrier, S. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-21721-3 · Cited by 5
Codiotoxicity of anthraciclines and the possibilities of its correction
Канорский, С. Г., & Pavlovets, V. P. (2023) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2023-4-3-7-14 · Cited by 5
Zhou, Y., Yi, T., Luo, Q., HU, Y., & Peng, W. (2024) · Acta Poloniae Pharmaceutica - Drug Research · doi:10.32383/appdr/178491 · Cited by 5
Gökçe, Y., Danışman, B., & Çiçek, B. (2024) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1403862 · Cited by 5
Wang, Y., Wei, L., Liu, Y., Liu, C., Hou, M., Zhou, L., Wang, L., Li, H., Qiu, Y., & JingMa (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4622 · Cited by 5
Wang, Z., Yang, Y., Wang, N., Lu, L., Xu, C., Ren, J. T., & Yang, L. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05029-6 · Cited by 5
Goujani, S. M., Koopaie, M., Safarian, F. H., Hakimiha, N., & Younespour, S. (2024) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2024.104457 · Cited by 5
Noor, N. S., & Hamid, S. B. S. (2025) · Current Molecular Medicine · doi:10.2174/0115665240347014241203065055 · Cited by 5
Design, synthesis and biological evaluation of buthutin derivatives as cardioprotective agents
Liu, Y., Wang, F.-Q., Hua, X.-H., Wang, L., Wang, L.-N., Xu, Y.-S., Shao, C.-Y., Gou, X.-B., & Liu, Y. (2025) · Natural Products and Bioprospecting · doi:10.1007/s13659-025-00497-9 · Cited by 5
Hou, X., Xie, S., Zhou, N., Wei, S., Yang, Y., Luo, Z., Liu, S., Li, J., Xie, N., Li, W., et al. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70093 · Cited by 5
Hazari, V., Shahsavari, L., & Sadri, F. (2025) · Journal of Cancer Biomoleculars and Therapeutics · doi:10.62382/jcbt.v2i2.59 · Cited by 5
Abdrabou, R. D., Salama, R. M., El‐Naga, R. N., & Azab, S. S. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00793-8 · Cited by 5
Dutta, B., Loo, S., Kam, A., Wang, X., Wei, N., Luo, K. Q., Liu, C., & Tam, J. P. (2025) · Antioxidants · doi:10.3390/antiox14040493 · Cited by 5
Protective effect of omega-3 on reducing doxorubicin toxicity in preclinical trials
de Paiva, M. H., de Almeida, S., Garcia, C. B., Pereira, P. M., Martins, J. G., Stante, F. H. R., Lucera, T. M. C., Dias, F. G. G., Furtado, R. A., & Paulino, D. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102056 · Cited by 5
Chen, S., Jiang, C., Yi, X., Shu, Q., Feng, Y., Zhong, L., Huang, M., Zhu, J., & Fang, L. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152196 · Cited by 5
The Role of Mitochondrial Dynamics in Doxorubicin‐Induced Disease: Implications for Therapy
Yue, H., CHEN, Y.-S., Feng, J., Yue, W., & Shi, X. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70064 · Cited by 5
Lü, J., Shen, C., Ma, W., Lin, Z., & Gao, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-18383-2 · Cited by 5
Cardioprotective Effects of Simvastatin in Doxorubicin-Induced Acute Cardiomyocyte Injury
Vitale, R., Mazzone, M., Marcantonio, M. C. D., Marzocco, S., Mincione, G., & Popolo, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199440 · Cited by 5
Hong, Q., Mai, P., Wu, B., Wang, H., Xiao, M., & You, J. (2022) · Environmental Toxicology · doi:10.1002/tox.23602 · Cited by 5
Labdane conjugates protect cardiomyocytes from doxorubicin‐induced cardiotoxicity
Cuadrado, I., Oramas‐Royo, S., González‐Cofrade, L., Amesty, Á., Hortelano, S., Estévez‐Braun, A., & Heras, B. D. L. (2022) · Drug Development Research · doi:10.1002/ddr.22014 · Cited by 5
Doxorubicin inhibits cholesterol efflux through the miR-33/ABCA1 pathway
Zhu, F., Chang, G., Tang, X., Gao, L., & Zhang, N. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.024 · Cited by 5
Chen, H., Liu, C., Yu, S., Zhou, H., Shafiq, F., & Qiao, W. (2023) · Langmuir · doi:10.1021/acs.langmuir.3c00439 · Cited by 5
Lü, F., Zhong, J., Liu, H., & Xiao, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1258464 · Cited by 5
Natesh, J., Mondal, P., Penta, D., Mukhlis, Y., Haware, D. J., & Meeran, S. M. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4588 · Cited by 5
Structure-activity relationship of anticancer drug candidate quinones
Özenver, N., SÖNMEZ, N., Baran, M. Y., Kuruüzüm‐Uz, A., & Demirezer, L. Ö. (2024) · TURKISH JOURNAL OF CHEMISTRY · doi:10.55730/1300-0527.3647 · Cited by 6
Dai, Q., Pan, Y., Zhu, X., Chen, M., Xie, L., Zhu, Y., & Wan, G. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128289845240305070522 · Cited by 5
Cırrık, S., Kabartan, E., Hacıoğlu, G., & Peker, E. G. G. (2024) · Journal of Academic Research in Medicine · doi:10.4274/jarem.galenos.2024.27676 · Cited by 5
Protective effects of cupressuflavone against doxorubicin-induced hepatic damage in rats
Hayat, M. F., Batool, M., Ahmed, H. G., Azmat, R., Ahmed, M., & Riaz, M. N. (2024) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2024.103240 · Cited by 5
Ebbert, L., von Montfort, C., Wenzel, C.-K., Reichert, A. S., Stahl, W., & Brenneisen, P. (2024) · Antioxidants · doi:10.3390/antiox13070864 · Cited by 5
Identification of autophagy-related signatures in doxorubicin-induced cardiotoxicity
Wu, H., Chen, H., Ding, X., Kuang, X., Pang, M., Liu, S., Zhang, Y., Wang, Q., Li, K., & Zhang, H. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117082 · Cited by 5
Susianti, S., Bahri, S., Hadi, S., Setiawansyah, A., Rachmadi, L., Fadilah, I., & Ratna, M. G. (2024) · Journal of Multidisciplinary Applied Natural Science · doi:10.47352/jmans.2774-3047.228 · Cited by 5
2-[18F]Fluoropropionic Acid PET Imaging of Doxorubicin-Induced Cardiotoxicity
Azcona, J. A., Wacker, A. S., Lee, C., Fung, E. K., Jeitner, T. M., Manzo, O. L., Lorenzo, A. D., Babich, J. W., Amor‐Coarasa, A., & Kelly, J. M. (2025) · Molecular Imaging and Biology · doi:10.1007/s11307-024-01978-y · Cited by 5
Ifora, I., Dachriyanus, D., Susanti, M., & Wahyuni, F. S. (2025) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v15i2.7022 · Cited by 5
Vitale, R., Marzocco, S., & Popolo, A. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70214 · Cited by 5
Synergy of Microfluidics and Nanomaterials: A Revolutionary Approach for Cancer Management
Pramoda, G., Singh, M., Gupta, P. K., & Shukla, R. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00123 · Cited by 5
Noncoding RNA-Associated Competing Endogenous RNA Networks in Doxorubicin-Induced Cardiotoxicity
Xiao, Z., Wei, S., Huang, J., Liu, J., Liu, J., Zhang, B., & Li, W. (2022) · DNA and Cell Biology · doi:10.1089/dna.2022.0022 · Cited by 5
Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection
Yoon, C. S., Nifantiev, N. E., Yashunsky, D. V., Kim, H. K., & Han, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115232 · Cited by 5
Bodla, Z. H., Hashmi, M., Niaz, F., Farooq, U., Khalid, F., Tariq, M. J., Khalil, M. J., Brown, V. S., & Bray, C. L. (2023) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2023.2267921 · Cited by 5
Zhu, W., Lian, N., Jia, W., Fengming, Z., Liu, B., Sheng, J., Zhang, C., Zhou, X., Wenbai, G., Chen, X., et al. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00955-5 · Cited by 5
Empagliflozin to Prevent Doxorubicin Cardiotoxicity
Guo, Z., & Javaheri, A. (2025) · JACC CardioOncology · doi:10.1016/j.jaccao.2025.01.005 · Cited by 5
Zhao, W., Noor, K. S., Sun, S., Xu, H., Meng, J., He, X., & Sheng, W. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503947 · Cited by 4
Zhou, J., Shen, W., Feng, W., Zhang, X., Wu, T., Zhou, J., Su, Z., & Yin, T. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c02978 · Cited by 4
A peptide alleviated oxidative damages in the L02 cells and mice liver
Gao, G., Zhang, Z., Wang, Q., Xie, Z., Liu, B., & Huang, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150643 · Cited by 4
Alqudah, A. M., Qnais, E. Y., Bseiso, Y., Shilbayeh, S. A. R., Aljabali, A. A. A., & Gammoh, O. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177731 · Cited by 4
Non-Coding RNAs in the Regulation of Doxorubicin-Induced Cardiotoxicity
Sun, M., Kim, I., & Yang, L. (2025) · Biomolecules · doi:10.3390/biom15060800 · Cited by 4
Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
Bai, R., Zhao, Z., Xing, H., Shang, M., Liu, G., Xu, F., & Cai, S. (2025) · Molecules · doi:10.3390/molecules30122527 · Cited by 4
DDX3X/MAVS alleviates doxorubicin‑induced cardiotoxicity by regulating stress granules
Zhao, K., Wang, S., Feng, D., Wang, D., Yang, G., & Lang, F. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13602 · Cited by 4
Mathew, D. M., & Gopalakrishnan, A. V. (2025) · Medical Oncology · doi:10.1007/s12032-025-03012-9 · Cited by 4
Li, H., Wu, Y., Guo, Q., Guo, C., Liu, F., & Huo, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1680909 · Cited by 4
Chemo-/radiotherapy-induced cardiomyopathy: roles of mitochondria and endoplasmic reticulum
Suliman, M., Altalbawy, F. M. A., Malathi, H., Kazmi, S. W., Sharma, A., Kumar, M., Alamir, H. T. A., Mohammed, F., KADHIM, A. J., & Alhadrawi, M. (2025) · Strahlentherapie und Onkologie · doi:10.1007/s00066-025-02471-3 · Cited by 4
Wang, Z., Liu, X., Zhu, X., Hu, S., Zhang, K., Li, X., Nie, B., & Sun, Y. (2025) · Small · doi:10.1002/smll.202508419 · Cited by 5
Vesmaker, K., Venkadakrishnan, J., & Dhar, A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178356 · Cited by 4
Cao, J., Hong, X., Li, D., Jiang, W., & Yang, W. (2025) · Cancers · doi:10.3390/cancers18010117 · Cited by 4
Metadata
- Authors
- Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U.
- Affiliations
- Central University of Punjab (IN)
- P.V. Narsimha Rao Telangana Veterinary University (IN)
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 139
- Pages
- 111708
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W3160992829
- Cited by
- 909
- References
- 198
- Citations by year
- 2026: 171 · 2025: 232 · 2024: 208 · 2023: 193 · 2022: 92 · 2021: 13
- FWCI
- 24.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicine & Pharmacotherapy (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Royal Society of Medicine
- University of Central Punjab (GP-25)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- doxorubicin, cardiotoxicity, molecular mechanisms, DNA methylation, DNMT1, mitochondrial dysfunction, PGC-1α, NRF1, TFAM, microRNA, histone deacetylase, autophagy, apoptosis, nitric oxide, inflammatory mediators, cardioprotection, anthracycline chemotherapy
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Doxorubicin, Humans, Mitochondria, Heart, Apoptosis, Oxidative Stress, Cardiotoxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review